Patents by Inventor Mengtong Duan

Mengtong Duan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357780
    Abstract: Provided herein are genetically engineered gas vesicle expression systems (GVES) that are configured to express gas vesicles (GVs) in a mammalian cell, related gas vesicle polynucleotide constructs, gas vesicle reporting genetic circuits, vectors, genetically engineered mammalian cells, non-human mammalian hosts, compositions, methods and systems, which in several embodiments can be used together with contrast-enhanced imaging techniques to detect and report biological events in an imaging target site comprising a mammalian cell and/or organism.
    Type: Application
    Filed: May 15, 2023
    Publication date: November 9, 2023
    Inventors: Arash FARHADI, Gabrielle H HO, Daniel P SAWYER, Mikhail SHAPIRO, Robert C. HURT, Mengtong DUAN
  • Patent number: 11761008
    Abstract: Provided herein are genetically engineered gas vesicle expression systems (GVES) that are configured to express gas vesicles (GVs) in a mammalian cell, related gas vesicle polynucleotide constructs, gas vesicle reporting genetic circuits, vectors, genetically engineered mammalian cells, non-human mammalian hosts, compositions, methods and systems, which in several embodiments can be used together with contrast-enhanced imaging techniques to detect and report biological events in an imaging target site comprising a mammalian cell and/or organism.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: September 19, 2023
    Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Arash Farhadi, Gabrielle H Ho, Daniel P Sawyer, Mikhail Shapiro, Robert C. Hurt, Mengtong Duan
  • Publication number: 20230210926
    Abstract: Disclosed herein include methods, compositions, and kits suitable for use in dynamic non-destructive imaging. The non-destructive imaging can be nonlinear ultrasound imaging. There are provided, in some embodiments, nucleic acid compositions encoding gas vesicles (GVs) capable of producing nonlinear ultrasound contrast upon expression in a prokaryotic cell (e.g., a probiotic bacterial cell) or a eukaryotic cell (e.g., a therapeutic mammalian cell).
    Type: Application
    Filed: December 15, 2022
    Publication date: July 6, 2023
    Inventors: Marjorie T. Buss, Robert C. Hurt, Katie K. Wong, Mikhail G. Shapiro, Mengtong Duan, Arash Farhadi, Mei Yi You
  • Patent number: 11649462
    Abstract: Provided herein are genetically engineered gas vesicle expression systems (GVES) that are configured to express gas vesicles (GVs) in a mammalian cell, related gas vesicle polynucleotide constructs, gas vesicle reporting genetic circuits, vectors, genetically engineered mammalian cells, non-human mammalian hosts, compositions, methods and systems, which in several embodiments can be used together with contrast-enhanced imaging techniques to detect and report biological events in an imaging target site comprising a mammalian cell and/or organism.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 16, 2023
    Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Arash Farhadi, Gabrielle H Ho, Daniel P Sawyer, Mikhail Shapiro, Robert C. Hurt, Mengtong Duan
  • Publication number: 20230016245
    Abstract: Disclosed herein include methods, compositions, and kits enabling expression of multiple proteins from a single mRNA with a predetermined stoichiometry. There are provided, in some embodiments, nucleic acid compositions comprising a promoter operably linked to a polynucleotide comprising a first nucleic acid unit encoding first unit payload protein(s) and a second nucleic acid unit encoding second unit payload protein(s). The first nucleic acid unit and the second nucleic acid unit can each comprise a 3? engineered translation initiation site (eTIS) comprising a three-nucleotide tunable element immediately upstream of a start codon. The eTIS of each of the first nucleic acid unit and the second nucleic acid unit can be configured to achieve a predetermined stoichiometry of the first unit payload protein(s) and the second unit payload protein(s) in a cell or cell-like environment.
    Type: Application
    Filed: July 15, 2022
    Publication date: January 19, 2023
    Inventors: Mengtong Duan, Mikhail G. Shapiro